Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 18;188(19):5157-5174.e20.
doi: 10.1016/j.cell.2025.06.002. Epub 2025 Jun 30.

Deconstructing the intercellular interactome in vascular dementia with focal ischemia for therapeutic applications

Affiliations

Deconstructing the intercellular interactome in vascular dementia with focal ischemia for therapeutic applications

Min Tian et al. Cell. .

Abstract

Vascular dementia (VaD), the second-leading cause of dementia, is primarily a white matter ischemic disease with no direct therapies. Cell-cell interactions within lesion sites dictate disease progression or repair. To elucidate key intercellular pathways, we employ a VaD mouse model with focal ischemia replicating many elements of the complex pathophysiology of human VaD combined with transcriptomic and functional analyses. By integrating cell-type-specific mouse VaD transcriptomes and human VaD single-nucleus RNA sequencing (snRNA-seq) data plus a custom ligand-receptor database (4,053 human and 2,032 mouse pairs), conserved dysregulated intercellular pathways in both species are identified. We demonstrate that two intercellular signaling systems, Serpine2-Lrp1 and CD39-A3AR, are disrupted in VaD. Reduced Serpine2 expression enhances oligodendrocyte progenitor cell (OPC) differentiation, promoting repair, while an A3AR-specific agonist-currently in clinical trials for psoriasis-restores tissue integrity and behavioral function in the VaD model. This study reveals intercellular signaling targets and provides a foundation for developing innovative therapies for VaD.

Keywords: A3AR; CD39; L-R pairs; Serpine2; VaD; WM; adenosine receptor 3; cell-cell interaction; glia; learning and memory; ligand-receptor pairs; motor deficit; stroke; tissue repair; vascular dementia; white matter.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.T. and S.T.C. are applying for a patent related to this work.

References

    1. Attems J, and Jellinger KA (2014). The overlap between vascular disease and Alzheimer’s disease - lessons from pathology. BMC Med. 12, 206. - PMC - PubMed
    1. McShane R, Westby. MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, and Debarros J (2019). Memantine for dementia. Cochrane Database Syst. Rev 3, CD003154. - PMC - PubMed
    1. Farooq MU, Min J, Goshgarian C, and Gorelick PB (2017). Pharmacotherapy for Vascular Cognitive Impairment. CNS Drugs 31, 759–776. - PubMed
    1. Iadecola C, Duering M, and Hachinski V, Joutel A, Pendlebury ST, Schneider JA, Dichgans M (2019). Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. J. Am. Coll. Cardiol 73, 3326–3344. - PMC - PubMed
    1. Inoue Y, Shue F, Bu G, and Kanekiyo T (2023). Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease. Mol. Neurodegener 18, 46. - PMC - PubMed

LinkOut - more resources